BD, AITbiotech Ink Distribution Pact for MDx Assays in Asia-Pacific | GenomeWeb

NEW YORK (GenomeWeb) — Becton Dickinson will distribute AITbiotech's molecular assays in the Asia-Pacific region, the companies said late last week.

Under the agreement, Becton Dickinson Holdings, BD's Singapore-based subsidiary, will distribute AITbiotech's abTES BM qPCR assays optimized for use on the BD Max molecular testing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.